Skip to main content

and
  1. Article

    Open Access

    Plasma neuregulin 1 as a synaptic biomarker in Alzheimer’s disease: a discovery cohort study

    Synaptic dysfunction is an early core feature of Alzheimer’s disease (AD), closely associated with cognitive symptoms. Neuregulin 1 (NRG1) is a growth and differentiation factor with a key role in the developm...

    Agathe Vrillon, François Mouton-Liger, Matthieu Martinet in Alzheimer's Research & Therapy (2022)

  2. Article

    Open Access

    CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease

    The presynaptic protein neuregulin1 (NRG1) is cleaved by beta-site APP cleaving enzyme 1 (BACE1) in a similar way as amyloid precursor protein (APP) NRG1 can activate post-synaptic receptor tyrosine-protein ki...

    François Mouton-Liger, Julien Dumurgier, Emmanuel Cognat in Alzheimer's Research & Therapy (2020)

  3. Article

    Open Access

    Are ketogenic diets promising for Alzheimer’s disease? A translational review

    Brain amyloid deposition and neurofibrillary tangles in Alzheimer’s disease (AD) are associated with complex neuroinflammatory reactions such as microglial activation and cytokine production. Glucose metabolis...

    Matthieu Lilamand, Baptiste Porte, Emmanuel Cognat in Alzheimer's Research & Therapy (2020)

  4. Article

    Open Access

    PKR involvement in Alzheimer’s disease

    Brain lesions in Alzheimer’s disease (AD) are characterized by Aβ accumulation, neurofibrillary tangles, and synaptic and neuronal vanishing. According to the amyloid cascade hypothesis, Aβ1-42 oligomers could...

    Jacques Hugon, François Mouton-Liger, Julien Dumurgier in Alzheimer's Research & Therapy (2017)

  5. Article

    Open Access

    Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study

    Affective and psychotic disorders are mental or behavioural patterns resulting in an inability to cope with life’s ordinary demands and routines. These conditions can be a prodromal event of Alzheimer’s diseas...

    Claire Paquet, Eloi Magnin, David Wallon in Alzheimer's Research & Therapy (2016)

  6. Article

    Open Access

    Neuroinflammation and Aβ Accumulation Linked To Systemic Inflammation Are Decreased By Genetic PKR Down-Regulation

    Alzheimer's disease (AD) is a neurodegenerative disorder, marked by senile plaques composed of amyloid-β (Aβ) peptide, neurofibrillary tangles, neuronal loss and neuroinflammation. Previous works have suggeste...

    Anne-Sophie Carret-Rebillat, Clarisse Pace, Sarah Gourmaud in Scientific Reports (2015)

  7. No Access

    Article

    Impact of cerebro-spinal fluid biomarkers of Alzheimer’s disease in clinical practice: a multicentric study

    CSF biomarkers of Alzheimer’s disease are well validated in clinical research; however, their pragmatic utility in daily practice is still unappreciated. These biomarkers are used in routine practice accordin...

    François Mouton-Liger, David Wallon, Anne-Cécile Troussière in Journal of Neurology (2014)

  8. Article

    Open Access

    Neuroprotective role of PKR in a model of neurodegeneration due to mild impairment of oxidative metabolism

    François Mouton-Liger, Anne-Sophie Rebillat, Sarah Gourmaud in Molecular Neurodegeneration (2013)

  9. Article

    Open Access

    Peripheral inflammation increases PKR activation, Tau phosphorylation and amyloid β production in wild-type mice

    François Mouton-Liger, Anne-Sophie Rebillat, Clarisse Pace in Molecular Neurodegeneration (2013)